MS campaign to support people living with multiple sclerosis

It’s estimated that 130,000 people across the UK have multiple sclerosis (MS) – a condition which causes damage to the nerves in the brain and spinal cord – with 100 people diagnosed every week.

While the COVID-19 pandemic has challenged us all, people living with MS have experienced additional pressures that have affected their health and the way they interact with their health services.

A recent survey of 1,840 people living with MS, initiated and funded by Novartis Pharmaceuticals UK Ltd and developed in partnership with the Multiple Sclerosis Trust (MS Trust), found that:

• One in three hadn’t had a consultation with a neurologist for more than a year (it is recommended to see a neurologist and MS nurse at least once a year).
• Nearly half said their access to relevant care and support was affected in some way during the pandemic.
• Nearly one in five said they experienced disruption to appointment.

Aston spoke to David Martin, CEO at MS Trust and MS patient Phoebe Day.